home / stock / otlkw / otlkw short
Short Information | Outlook Therapeutics Inc. Series A Warrant (NASDAQ:OTLKW)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 36,752 |
Total Actual Volume | 846,627 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 1,838 |
Average Short Percentage | 9.26% |
Is there a OTLKW Short Squeeze or Breakout about to happen?
See the OTLKW Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-16-2022 | $0.02 | $0.03 | $0.035 | $0.01 | 156,240 | 600 | 0.38% |
02-15-2022 | $0.04 | $0.0306 | $0.04 | $0.02 | 122,537 | 1 | 0% |
02-14-2022 | $0.05 | $0.041 | $0.05 | $0.025 | 18,641 | 1,400 | 7.51% |
02-11-2022 | $0.0798 | $0.0499 | $0.096 | $0.02 | 78,034 | 3,046 | 3.9% |
02-10-2022 | $0.04 | $0.076 | $0.0797 | $0.0351 | 181,066 | 5,603 | 3.09% |
02-09-2022 | $0.0356 | $0.0341 | $0.0378 | $0.034 | 29,212 | 7,187 | 24.6% |
02-07-2022 | $0.039 | $0.0369 | $0.039 | $0.029 | 12,311 | 100 | 0.81% |
02-03-2022 | $0.0303 | $0.029 | $0.0305 | $0.029 | 11,304 | 403 | 3.57% |
02-02-2022 | $0.0302 | $0.0405 | $0.0416 | $0.0302 | 4,238 | 1,700 | 40.11% |
02-01-2022 | $0.0304 | $0.0416 | $0.0416 | $0.0304 | 26,501 | 1 | 0% |
01-31-2022 | $0.0425 | $0.0425 | $0.0425 | $0.04 | 34,160 | 1,400 | 4.1% |
01-26-2022 | $0.049 | $0.0499 | $0.05 | $0.0425 | 13,422 | 602 | 4.49% |
01-24-2022 | $0.0488 | $0.049 | $0.049 | $0.0488 | 3,111 | 539 | 17.33% |
01-11-2022 | $0.0787 | $0.07 | $0.0789 | $0.0521 | 12,024 | 463 | 3.85% |
01-10-2022 | $0.060201 | $0.0692 | $0.0695 | $0.0597 | 17,479 | 427 | 2.44% |
01-07-2022 | $0.0472 | $0.0795 | $0.0795 | $0.0472 | 24,397 | 2,300 | 9.43% |
01-06-2022 | $0.06 | $0.06 | $0.06 | $0.0461 | 22,776 | 1,200 | 5.27% |
01-05-2022 | $0.0815 | $0.0764 | $0.111 | $0.0411 | 58,327 | 6,644 | 11.39% |
01-04-2022 | $0.101 | $0.0988 | $0.101 | $0.0806 | 14,950 | 1,000 | 6.69% |
01-03-2022 | $0.117 | $0.1028 | $0.117 | $0.0999 | 5,897 | 2,136 | 36.22% |
News, Short Squeeze, Breakout and More Instantly...
Outlook Therapeutics Inc. Series A Warrant Company Name:
OTLKW Stock Symbol:
NASDAQ Market:
Outlook Therapeutics Inc. Series A Warrant Website:
Live video webcast on Tuesday, June 18 th at 12:00 PM ET ISELIN, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the commercialization and development of ONS-5010/LYTENAVA™ (bevacizumab-vikg; be...
LYTENAVA™ (bevacizumab gamma) becomes first ophthalmic formulation of bevacizumab to receive European Commission Marketing Authorization for the treatment of wet AMD European Commission decision applies automatically to all 27 EU Member States and, within 30 days, also to Iceland, ...
Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA™ (bevacizumab gamma) United Kingdom (UK) Marketing Authorization Application (MAA) submitted NORSE EIGHT fully underway in the U...